The ERISA Industry Committee has recommended a few policies that Senate Finance Committee Democrats could use to give Medicare-negotiated drug prices to employer-sponsored plans without running afoul of reconciliation rules, ERIC Executive Vice President of Public Affairs James Gelfand said Tuesday (Sept. 7). Democrats could charge an excise tax when commercial market prices are higher than Medicare prices, they could roll Medicare-negotiated rates into inflation caps, or they could provide tax incentives tied to whether drug companies charge the commercial...